Drug intelligence / Profile preview

4-aminobenzoic acid hydrazide

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

4-aminobenzoic acid hydrazide (4-ABAH) is a small molecule that acts as a potent and irreversible inhibitor of myeloperoxidase (MPO). MPO is a heme-containing peroxidase enzyme primarily expressed in neutrophils and monocytes, where it plays a critical role in the innate immune response by producing reactive oxygen species (ROS) such as hypochlorous acid (HOCl). While essential for host defense, excessive MPO activity is implicated in tissue damage across various inflammatory, cardiovascular, and neurodegenerative diseases. In oncology research, 4-ABAH is frequently used as a pharmacological tool to investigate the role of MPO-expressing innate immune cells in the tumor microenvironment. Preclinical studies have demonstrated that 4-ABAH can inhibit tumor NF-κB transcriptional activation and modulate tumor initiation and growth, effectively mimicking an MPO-null phenotype in animal models. It is primarily utilized as a research-use-only reagent in laboratory settings.

Other names
p-aminobenzhydrazide4-aminobenzohydrazide4-aminobenzhydrazide
02

Targets

MPO (Myeloperoxidase)

Beyond the preview

Go deeper on 4-aminobenzoic acid hydrazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-aminobenzoic acid hydrazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call